Literature DB >> 34772764

Factors Associated with Pain Treatment Satisfaction Among Patients with Chronic Non-Cancer Pain and Substance Use.

Leslie W Suen1, Vanessa M McMahan2, Christopher Rowe2, Sumeet Bhardwaj2, Kelly Knight2, Margot B Kushel2, Glenn-Milo Santos2, Phillip Coffin2.   

Abstract

INTRODUCTION: A better understanding of pain treatment satisfaction in patients with chronic noncancer pain (CNCP) and substance use is needed, especially as opioid prescribing policies are changing. We sought to identify factors associated with pain treatment satisfaction in individuals with CNCP on recent opioid therapy and prior or active substance use.
METHODS: An exploratory cross-sectional analysis using baseline data from a cohort study of 300 adults with CNCP receiving >20 morphine milligram equivalents of opioids for ≥3 of the preceding 12 months and prior or active substance use. Participants completed interviews, clinical assessments, urine drug screening, and medical chart review.
RESULTS: Participants were predominantly middle-aged (mean age 57.5 years), Black (44%), and cisgender men (60%). One-third (33%) had high, 28% moderate, and 39% low pain treatment satisfaction. Post-traumatic stress disorder (PTSD), tobacco use, past-year opioid discontinuation, and higher average pain scores were associated with lower satisfaction. HIV and prescription cannabis use were associated with higher satisfaction.
CONCLUSIONS: The relationship between PTSD and tobacco use with lower satisfaction should be explored to augment pain outcomes. Higher satisfaction among individuals with HIV and prescription cannabis use presents potential research areas to guide CNCP management and reduce reliance on opioid therapies. © Copyright 2021 by the American Board of Family Medicine.

Entities:  

Keywords:  Chronic Disease; Chronic Pain; Cross-Sectional Studies; Opioids; Patient Satisfaction; Policy; Primary Health Care; Prospective Studies

Mesh:

Substances:

Year:  2021        PMID: 34772764      PMCID: PMC8813175          DOI: 10.3122/jabfm.2021.06.210214

Source DB:  PubMed          Journal:  J Am Board Fam Med        ISSN: 1557-2625            Impact factor:   2.395


  69 in total

1.  Validity of the Brief Symptom Inventory-18 (BSI-18) for identifying depression and anxiety in young adult cancer survivors: Comparison with a Structured Clinical Diagnostic Interview.

Authors:  Christopher J Recklitis; Jaime E Blackmon; Grace Chang
Journal:  Psychol Assess       Date:  2017-01-12

2.  A synthesis of oral morphine equivalents (OME) for opioid utilisation studies.

Authors:  Suzanne Nielsen; Louisa Degenhardt; Bianca Hoban; Natasa Gisev
Journal:  Pharmacoepidemiol Drug Saf       Date:  2015-12-22       Impact factor: 2.890

3.  Opioid medication discontinuation and risk of adverse opioid-related health care events.

Authors:  Tami L Mark; William Parish
Journal:  J Subst Abuse Treat       Date:  2019-05-05

4.  The risks of opioid treatment: Perspectives of primary care practitioners and patients from safety-net clinics.

Authors:  Emily E Hurstak; Margot Kushel; Jamie Chang; Rachel Ceasar; Kara Zamora; Christine Miaskowski; Kelly Knight
Journal:  Subst Abus       Date:  2017-04-10       Impact factor: 3.716

Review 5.  Understanding Risk Factors for Opioid Overdose in Clinical Populations to Inform Treatment and Policy.

Authors:  Tae Woo Park; Lewei Allison Lin; Avinash Hosanagar; Amanda Kogowski; Katie Paige; Amy S B Bohnert
Journal:  J Addict Med       Date:  2016 Nov/Dec       Impact factor: 3.702

6.  Brief Report: The Association of Chronic Pain and Long-Term Opioid Therapy With HIV Treatment Outcomes.

Authors:  Jessica S Merlin; Dustin Long; William C Becker; Edward R Cachay; Katerina A Christopoulos; Kasey Claborn; Heidi M Crane; E Jennifer Edelman; Richard Harding; Stefan G Kertesz; Jane M Liebschutz; W Christopher Mathews; Michael J Mugavero; Sonia Napravnik; Connall C OʼCleirigh; Michael S Saag; Joanna L Starrels; Robert Gross
Journal:  J Acquir Immune Defic Syndr       Date:  2018-09-01       Impact factor: 3.731

Review 7.  Efficacy and adverse effects of medical marijuana for chronic noncancer pain: Systematic review of randomized controlled trials.

Authors:  Amol Deshpande; Angela Mailis-Gagnon; Nivan Zoheiry; Shehnaz Fatima Lakha
Journal:  Can Fam Physician       Date:  2015-08       Impact factor: 3.275

8.  Correlations between opioid mortality increases related to illicit/synthetic opioids and reductions of medical opioid dispensing - exploratory analyses from Canada.

Authors:  Benedikt Fischer; Wayne Jones; Mark Tyndall; Paul Kurdyak
Journal:  BMC Public Health       Date:  2020-01-31       Impact factor: 3.295

9.  Changes in pain intensity after discontinuation of long-term opioid therapy for chronic noncancer pain.

Authors:  Sterling McPherson; Crystal Lederhos Smith; Steven K Dobscha; Benjamin J Morasco; Michael I Demidenko; Thomas H A Meath; Travis I Lovejoy
Journal:  Pain       Date:  2018-10       Impact factor: 7.926

10.  "Chasing the pain relief, not the high": Experiences managing pain after opioid reductions among patients with HIV and a history of substance use.

Authors:  Emily Behar; Rita Bagnulo; Kelly Knight; Glenn-Milo Santos; Phillip O Coffin
Journal:  PLoS One       Date:  2020-03-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.